Genome Compiler
ExitedPersonalized synthetic genome design
Genome Compiler has raised €5.8M across 2 funding rounds from 1 investor, most recently a Series A round in Jun 2015. Based in Tel Aviv, Israel; founded 2011; active in Healthtech. Acquired by Twist Bioscience in 2016. Data as of 4 Nov 2026.
Total raised
€5.8M
€5,750,000
Funding rounds
2
Investors
1
distinct backers
Active since
2013-10
latest 2015-06
Funding by year
EUR raised per yearGenome Compiler — funding by year — interactive chart.
Data table
| Genome Compiler — funding by year | |
|---|---|
| 2013 | €0 |
| 2015 | €5.8M |
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-06-01 | Series A | €5.8M | — | View deal → |
| 2013-10-01 | Seed | — | Techammer | View deal → |
Exit
Type
acquisition
Date
Feb 2016
Value
—
Acquiror
Twist Bioscience (United States San Francisco)